These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12897907)

  • 1. Hepatitis C virus seroprevalence rate among Saudis.
    Shobokshi OA; Serebour FE; Al-Drees AZ; Mitwalli AH; Qahtani A; Skakni LI
    Saudi Med J; 2003 Jul; 24 Suppl 2():S81-6. PubMed ID: 12897907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
    Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
    Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia.
    Shobokshi OA; Serebour FE; Skakni LI
    Saudi Med J; 2003 Jul; 24 Suppl 2():S87-91. PubMed ID: 12897908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia.
    Memish ZA; Knawy BA; El-Saed A
    Int J Infect Dis; 2010 Feb; 14(2):e115-20. PubMed ID: 19540786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.
    El Beltagy KE; Al Balawi IA; Almuneef M; Memish ZA
    Int J Infect Dis; 2008 Sep; 12(5):495-9. PubMed ID: 18400539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
    Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
    Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.
    Fathalla SE; Al-Jama AA; Al-Sheikh IH; Islam SI
    Saudi Med J; 2000 Oct; 21(10):945-9. PubMed ID: 11369959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C virus among bilharziasis patients.
    Khan ZA; Alkhalife IS; Fathalla SE
    Saudi Med J; 2004 Feb; 25(2):204-6. PubMed ID: 14968219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk.
    Daw MA; Elkaber MA; Drah AM; Werfalli MM; Mihat AA; Siala IM
    Saudi Med J; 2002 Nov; 23(11):1356-60. PubMed ID: 12506296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia.
    Njoh J; Zimmo S
    East Afr Med J; 1997 Feb; 74(2):89-91. PubMed ID: 9185392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR; Pophali A; Al-Abdul Rahim KA
    Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital.
    Al-Tawfiq JA; Anani A
    Med Sci Monit; 2008 Jan; 14(1):CR52-56. PubMed ID: 18160946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
    Sakarya S; Oncu S; Ozturk B; Oncu S
    Saudi Med J; 2004 Aug; 25(8):1070-2. PubMed ID: 15322600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Hepatitis C viral antibodies in pregnancy in a tertiary health facility in Nigeria.
    Onakewhor JU; Okonofua FE
    Niger J Clin Pract; 2009 Mar; 12(1):65-73. PubMed ID: 19562925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hepatitis C virus core antigenemia in Saudi drug users.
    Alzahrani AJ
    Saudi Med J; 2005 Oct; 26(10):1645-6. PubMed ID: 16228075
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C infection in Louisiana.
    Sokol TM; Lewis BE; Straif-Bourgeois S; Talati G; Ratard RC
    J La State Med Soc; 2005; 157(2):98-102. PubMed ID: 16022276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia.
    Madani TA
    Trans R Soc Trop Med Hyg; 2009 Feb; 103(2):132-6. PubMed ID: 18789464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors].
    Dieye TN; Gadji M; Cisse Y; Diallo TA; Toure Falla O; Diop S; Diallo S; Thiam D; Diakhate L
    Dakar Med; 2006; 51(1):47-52. PubMed ID: 16924850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.